↓ Skip to main content

MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating

Overview of attention for article published in Tumor Biology, November 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
30 Mendeley
Title
MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating
Published in
Tumor Biology, November 2014
DOI 10.1007/s13277-014-2771-6
Pubmed ID
Authors

Qingchao Tang, Zhaoxia Zou, Chendan Zou, Qian Zhang, Rui Huang, Xu Guan, Qiang Li, Zhongjing Han, Dayong Wang, Huiyan Wei, Xu Gao, Xishan Wang

Abstract

MicroRNA-93 (miR-93) is involved in several carcinoma progressions. It has been reported that miR-93 acts as a promoter or suppressor in different tumors. However, till now, the role of miR-93 in colon cancer is unclear. Herein, we have found that expression of miR-93 was lower in human colon cancer tissue and colorectal carcinoma cell lines compared with normal colon mucosa. Forced expression of miR-93 in colon cancer cells inhibits colon cancer invasion, migration, and proliferation. Furthermore, miR-93 may downregulate the Wnt/β-catenin pathway, which was confirmed by measuring the expression level of the β-catenin, axin, c-Myc, and cyclin-D1 in this pathway. Mothers against decapentaplegic homolog 7 (Smad7), as an essential molecular protein for nuclear accumulation of β-catenin in the canonical Wnt signaling pathway, is predicted as a putative target gene of miR-93 by the silico method and demonstrated that it may be suppressed by targeting its 3'UTR. These findings showed that miR-93 suppresses colorectal cancer development via downregulating Wnt/β-catenin, at least in part, by targeting Smad7. This study revealed that miR-93 is an important negative regulator in colon cancer and suggested that miR-93 may serve as a novel therapeutic agent that offers benefits for colon cancer treatment.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Hungary 1 3%
Unknown 28 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 33%
Student > Bachelor 5 17%
Researcher 4 13%
Student > Master 3 10%
Student > Postgraduate 2 7%
Other 3 10%
Unknown 3 10%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 37%
Agricultural and Biological Sciences 8 27%
Medicine and Dentistry 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Psychology 1 3%
Other 3 10%
Unknown 2 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2014.
All research outputs
#17,495,423
of 25,663,438 outputs
Outputs from Tumor Biology
#1,161
of 2,679 outputs
Outputs of similar age
#167,116
of 276,942 outputs
Outputs of similar age from Tumor Biology
#52
of 138 outputs
Altmetric has tracked 25,663,438 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,679 research outputs from this source. They receive a mean Attention Score of 2.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,942 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.